CRISPR and Genome Editing – Products

Sino Biological is pleased to announce an expansion of its strategic partnership with BioGeometry.

Nona Biosciences, announced that it has entered into a multi-target antibody discovery collaboration with Umoja Biopharma. This collaboration leverages Nona's proprietary fully human heavy chain only antibody (HCAb) technology.

Amy DuRoss, former CEO of Vineti, joins Advisory Board to help Kosten Digital expand its markets and integrate its AI solutions with life science partners.

Stem cell charity Anthony Nolan has announced the opening of the Anthony Nolan Cell Collection Centre in Nottingham, UK.

Archer CGP research assays now enable homologous recombination deficiency (HRD) assessment for identification of key biomarkers critical for cancer research.

Rentschler Biopharma SE, announced the launch of an expanded service offering at its dedicated advanced therapies site in Stevenage, UK.

This whitepaper explores the available technologies, key challenges and the growing impact of single-cell cloning.

Partnership provides Medicines Discovery Catapult access to CRISPR gene editing technology across a broad range of drug discovery applications.

Automated robotic instruments are revolutionizing scientific research and bringing more productivity and throughput to routine single-cell isolation workflows. This eBook highlights image-based systems simplify progress in many research applications.

BioSpring GmbH and Pantherna Therapeutics GmbH, have agreed on a strategic collaboration in the field of research and development and signed a cooperation agreement mid-July.